Recent Posts
Travis’s Story of Wilson Disease
Rare and Rural By Rhonda Rowland, WDA President We all love a small town. Images come to mind of holiday [...]
Newborn Screening for Wilson Disease
A 25-year dream coming close to reality By Alice Williams, WDA Communications Director Since the 1960s, the United States has [...]
Can Copper be Absorbed Through the Skin?
By Edward Tabor, MD, WDA Board Member The main source of copper for humans is food, and Wilson disease patients [...]
They Said “Yes” to Gene Therapy
By Rhonda Rowland, WDA PresidentWe continue the story of two trailblazers who are among the first Wilson disease (WD) patients [...]
Meet the Inaugural Gene Therapy Candidates
By Rhonda Rowland, WDA President The two gene therapy clinical trials for Wilson disease (WD) launched by Ultragenyx and [...]
The 100th Registry Participant
By Rhonda Rowland, WDA President I’m study participant number 30 in the Wilson Disease (WD) Patient Registry. That’s not exciting. [...]
Registration and availability of Trientine hydrochloride – Canada
IMPORTANT ANNOUNCEMENT Registration and availability of Trientine hydrochloride (Health Canada Drug Identification Number: 02515067
Waymade Canada Inc. wishes to advise that Waymade-Trientine (Trientine dihydrochloride) 250mg capsule bottle (x100) was registered with Health Canada on the 4th of April 2021.
The distribution of Waymade-Trientine (Trientine hydrochloride) 250mg capsule is managed by Waymade Canada Inc. Trientine Waymade is available for ordering, please find ordering and product enquiry information below;
For any enquiries, please contact:
Max Belanger
Phone: 1-514-571-6729
Email: max.belanger@waymade.ca
Stock is currently available to order with Waymade Canada Inc: WAYMADE-CSR@innomar-strategies.com
